Mobile Application Developed Based on the Thompson &Thompson Bioethical Decision-Making
18 de mayo de 2026 actualizado por: Asude GÜNEY, Necmettin Erbakan University
The Effect of a Mobile Application Developed Based on the Thompson &Thompson Bioethical Decision-Making Model on Nursing Students' Ethical Decision-Making and Ethical Sensitivity: A Randomized Controlled Study
Aim: The aim of this study is to examine the effect of a mobile application, developed based on the Thompson & Thompson bioethical decision-making model, on the ethical decision-making and ethical sensitivity of nursing students.
Method: This randomized controlled trial, planned with pre-, post-, and followup tests, will be conducted at Necmettin Erbakan University Faculty of Nursing during the 2026-2027 academic year.
The study population will consist of 4th-year students enrolled in the Necmettin Erbakan University Faculty of Nursing during the 2026-2027 academic year.
The sample size was statistically calculated using the G Power 3.1.9.7 software package.
The total sample size was calculated as 82.
To prevent data loss, the sample size was increased by 10%, resulting in a sample size of 90 students.
Students in the intervention group will use the mobile application.
Students in the control group will conduct face-toface case analysis.
The research data will be collected using the "Introductory Information Form", "Ethical Dilemma Test in Nursing" and "Adapted Ethical Sensitivity Scale for Nursing Students".
The data will be analyzed using the IBM SPSS 22 software package.
Conclusion: As a result of the research, it is predicted that the mobile application developed based on the Thompson & Thompson bioethical decision-making model will have a positive effect on the ethical decision-making and sensitivity levels of nursing students.
Descripción general del estudio
Estado
Aún no reclutando
Tipo de estudio
Intervencionista
Inscripción (Estimado)
90
Fase
- No aplica
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Being a 4th-year nursing student.
- Having taken and successfully passed the Professional Ethics course.
- Having a mobile device and internet access.
- Willing to volunteer to participate in the research.
Exclusion Criteria:
- Difficulty understanding and speaking Turkish
- Having a Cumulative Grade Point Average (CGPA) below 2.00
Exclusion criteria from the study:
- Experiencing problems with internet access
- Completing data collection forms incompletely/incorrectly
- Not attending any of the case study or case analysis sessions
- Wishing to withdraw from the study
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Experimental
Mobile Application Developed Based on the Thompson & Thompson Bioethical Decision-Making Model
|
Otro: Mobile Application Developed Based on the Thompson & Thompson Bioethical Decision-Making Model
The application content is a mobile application created by researchers and developed by a computer engineer.
The application will be compatible with both iOS and Android software.
Once the application is ready, it will be made available for download to the phones of the students in the intervention group.
The mobile application will have student and faculty login options.
Students will be able to register and log in to the application with their student numbers and a password they have chosen.
The application interface will include case studies, ethical statements, an ethics information library, and online support areas.
Six ethical case scenarios created by the researcher will be acted out with a patient and a nurse, and videos will be recorded.
Each of the recorded videos will be uploaded to the mobile application.
|
|
Otro: Control
Ethical case discussions
|
For case discussions with students in the control group, ethical cases from the book Ethical Decision Making in Nursing will be used.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Ethical decision-making
Periodo de tiempo: 3 months
|
Ethical decision-making will be assessed using the Nursing Ethical Dilemma Test.
The lowest possible Principled Thinking score is 18, and the highest is 66; the lowest Practical Thinking score is 6, and the highest is 36.
The sum of the scores for each dilemma constitutes an A score.
Accordingly, scores between 6 and 17 indicate that students are familiar with a similar dilemma, while scores between 18 and 30 indicate that they are not familiar with a similar dilemma.
|
3 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Ethical sensitivity
Periodo de tiempo: 3 months
|
Ethical sensitivity will be assessed using the Ethical Sensitivity Scale Adapted for Nursing Students.
The total score of the scale ranges from 30 to 210.
Higher scores indicate higher ethical sensitivity.
|
3 months
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
11 de enero de 2027
Finalización primaria (Estimado)
5 de marzo de 2027
Finalización del estudio (Estimado)
11 de junio de 2027
Fechas de registro del estudio
Enviado por primera vez
12 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
18 de mayo de 2026
Publicado por primera vez (Actual)
22 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
22 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
18 de mayo de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- NecmettinErbakanUU
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .